Tuesday, June 18, 2024

Market Access Today Partners with World Evidence, Access and Pricing Congress 2024: A Post-Event Report

Similar articles

The 15th edition of the World Evidence, Access and Pricing Congress, Europe’s premier Market Access and Pricing event, concluded with resounding success at the RAI Amsterdam. This year’s event, held in partnership with Market Access Today, saw a record-breaking attendance of 1200 participants, including industry leaders, decision-makers, and solution providers, all united to drive innovation in patient access and shape the industry’s future.

The conference has grown significantly over the past three years, with attendance doubling and making 2024 the largest event to date. The attendee breakdown was as follows: 31% from Pharmaceutical and Biotechnology sectors, 17% from Professional Advisory, Legal, and Consultancy, 10% from Solution Providers, CROs, AI, and Data Analytics Providers, and 7% from Government, HTA, Healthcare, Payer, and Regulators. Participants hailed from around the world, with notable representation from the United Kingdom (28%), the Netherlands (14%), Switzerland (9%), Germany (7%), and the USA (7%).

The conference featured insightful sessions from renowned speakers. Christoph Glaetzer, Chief Global Value and Access Officer at Janssen, spoke on mastering access agendas for patients now and in the future. Claus Runge, Senior Vice President, Global Head of Market Access, Public Affairs & Sustainability at Bayer, addressed overcoming the access barrier and promoting inclusive growth globally. Gerdi Strydom, Managing Director at Valid Insight, discussed integrating sustainability into healthcare decision-making beyond cost-effectiveness.

Experts Discuss Global Market Access, Pricing, and Equity at World Epa Congress 2024

Vivian Mendonca, Senior Vice President, Global Head of Market Access, Pricing, HEOR and External Affairs at Menarini Group, provided a global perspective on changing landscapes around market access and pricing. Charles Makin, Global Head of Real World Evidence & Epidemiology at Boehringer Ingelheim, spoke on optimizing market access and pricing by leveraging integrated evidence to demonstrate value. Jayasree Iyer, Chief Executive Officer at Access to Medicines Foundation, highlighted trends for affordable access and reducing disparities in global inequity.

The event covered diverse and critical topics through various conference tracks. The Evidence track focused on patient-centered outcomes, evidence generation, and real-world evidence. The Market Access track explored early access schemes, access in low- and middle-income countries (LMICs), and investment strategies. The Pricing track discussed reimbursement, value-based healthcare, pricing from start-up perspectives, and procurement practices. The Rare Diseases track included value-based therapies, payer engagement, launching products, and patient journey in accessing new treatments.

Market Access Today

Market Access Today Highlights Advanced Therapies and Digital Transformation at World Epa Congress 2024

The Advanced Therapies track addressed pricing approaches for gene therapies, early pipeline development, and managed entry agreements. The Digital Transformation track covered data analytics, digital therapeutics, and the use of data for Health Technology Assessments (HTAs). The HTA track discussed new EU HTA regulations, gaps in evidence, healthcare decision-making, and risk-sharing agreements. The Health Economics and Outcomes Research track included clinical outcomes assessments, innovating economic processes, modeling health inequalities, and broadening the definition of value.

Please click to access the details of the report.

The conference facilitated substantial networking opportunities, with over 2,400 contacts made, more than 70 total meetings, and over 900 discussions.

You can follow our news on our Telegram and LinkedIn accounts.

The 2024 World Evidence, Access and Pricing Congress was a landmark event that underscored the importance of collaboration and innovation in improving patient access and healthcare outcomes. Market Access Today is proud to have been a partner in this significant event, driving forward the conversation on market access and pricing in the healthcare industry.

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Latest article